-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pi3MBvEAMmhosCGjJTccgPRpclJ99Lb4uiQ7mnh3EbHlC4+I+H37RCp5cOn1zdzq YD/fLvy3GF5+5w+7t1h3LA== /in/edgar/work/0000950162-00-001273/0000950162-00-001273.txt : 20001128 0000950162-00-001273.hdr.sgml : 20001128 ACCESSION NUMBER: 0000950162-00-001273 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20001127 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20001127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENTIVA HEALTH SERVICES INC CENTRAL INDEX KEY: 0001096142 STANDARD INDUSTRIAL CLASSIFICATION: [7363 ] IRS NUMBER: 364335801 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-15669 FILM NUMBER: 776761 BUSINESS ADDRESS: STREET 1: 3 HUNTINGTON QUADRANGLE 2S CITY: MELVILLE STATE: NY ZIP: 11747-8943 BUSINESS PHONE: 6315017000 MAIL ADDRESS: STREET 1: 3 HUNTINGTON QUADRANGLE 2S CITY: MELVILLE STATE: NY ZIP: 11747-8943 FORMER COMPANY: FORMER CONFORMED NAME: OLSTEN HEALTH SERVICES HOLDING CORP DATE OF NAME CHANGE: 19991001 8-K 1 0001.txt FORM 8-K ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------------------ FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 27, 2000 Date of Report (Date of earliest event reported) GENTIVA HEALTH SERVICES, INC. (Exact name of registrant as specified in its charter) Delaware 1-15669 36-433-5801 (State or other jurisdiction of (Commission file number) (I.R.S. Employer incorporation or organization) Identification No.) 3 Huntington Quadrangle 2S, Melville, New York 11747-8943 (Address of principal executive offices) (631) 501-7000 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) ================================================================================ Item 5. Other events. On November 27, 2000, Gentiva Health Services, Inc. issued the press release attached as Exhibit 99 and incorporated by reference herein. Item 7. Exhibits. (c) Exhibits. The following exhibit is filed herewith: Exhibit No. Description ----------- ----------- (99) Press Release dated November 27, 2000 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: November 27, 2000 GENTIVA HEALTH SERVICES, INC. By: /s/ Patricia C. Ma -------------------------------------- Patricia C. Ma Senior Vice President, General Counsel and Secretary EX-99 2 0002.txt PRESS RELEASE FOR IMMEDIATE RELEASE Gentiva Health Services Intends to Challenge Ohio Judgement Melville, N.Y., November 27, 2000--Gentiva Health Services (Nasdaq: GTIV), the nation's leading provider of specialty pharmaceutical distribution and home health care services, today announced that it intends to vigorously pursue post-trial challenges to a verdict issued on November 22, 2000 in the Mahoning County, Ohio Court of Common Pleas. In this case, an age discrimination lawsuit first filed in 1998, a jury returned a verdict in favor of the plaintiff against Olsten Health Services Corp. and Olsten Corporation (the former parent of Gentiva Health Services), consisting of $675,000 in compensatory damages, $30 million in punitive damages, and an undetermined award of attorneys' fees. In connection with Gentiva's split-off from Olsten Corporation in March 2000, Gentiva agreed to assume all liabilities of Olsten Corporation arising out of its health services business and to indemnify Olsten Corporation for such liabilities. Gentiva announced this morning that the defendants will pursue a number of post-trial options in response to the verdict. The company strongly believes that there are meritorious grounds upon which to challenge the trial's outcomes. Gentiva this morning has filed Form 8-K in relation to the November 22, 2000 jury verdict. Gentiva Health Services (Nasdaq: GTIV) is the nation's leading provider of specialty pharmaceutical distribution and home health care services. With more than 300 locations in the United States, the company had approximately $1.5 billion in 1999 revenues. For more information, visit Gentiva's Web site, www.gentiva.com. Information contained in this news release, other than historical information, should be considered forward-looking, and is subject to various risk factors and uncertainties. For instance, the company's strategies and operations involve risks of competition, changing market conditions, changes in laws and regulations affecting our industries and numerous other factors discussed in this release and in the company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those anticipated in any forward-looking statements. Contact: Michael Johns Vice President, Communications Gentiva Health Services 3 Huntington Quadrangle, 2S Melville, NY 11747-8943 (631) 501-7442 michael.johns@gentiva.com Investor Contact: John J. Collura Executive Vice President, Chief Financial Officer and Treasurer Gentiva Health Services (631) 501-7437 -----END PRIVACY-ENHANCED MESSAGE-----